Introduction
Antioxidant response element (ARE) also referred to as electrophile response element (EpRE) was identi®ed in the promoters of several genes encoding detoxifying enzymes (Rushmore and Pickett, 1993; Jaiswal, 1994; Mulkahy et al., 1997) . ARE is known to mediate expression and coordinated induction of the various detoxifying enzyme genes. The detoxifying enzymes include NAD(P)H:quinone oxidoreductases (NQOs), which catalyze two-electron reduction and detoxification of quinones; glutathione S-transferase (GSTs), which conjugate hydrophobic electrophiles and reactive oxygen species (ROS) with glutathione; UDP-glucuronosyl transferase (UDP-GT), which catalyze the conjugation of glucuronic acid with xenobiotics and drugs; epoxide hydrolase, which inactivates epoxides; g-glutamylcysteine synthetase, which is a rate-limiting enzyme in the de novo synthesis of glutathione and so on (Venugopal et al., 1997) . Nucleotide sequence analysis of the various AREs revealed that they contain AP1/AP1 like elements arranged as inverse or direct repeats separated by three or eight nucleotides followed by a GC box (Jaiswal, 1994) . Mutational analysis of the ARE identi®ed GTGAC***GC as the core of the ARE sequence (Rushmore et al., 1991; Xie et al., 1995) . Additional cis-element and nucleotide sequences¯anking the core sequence have been shown to contribute to the ARE-mediated expression and induction (Prestera et al., 1993; Bergelson et al., 1994; Xie et al., 1995; Wasserman and Fahl, 1997) .
Nuclear transcription factors c-Jun, Jun-B, Jun-D, cFos, Fra1, Nrf1, Nrf2, YABP, ARE-BP1 and Ah receptor have been reported to bind to the AREs from the various genes (Li and Jaiswal, 1992; Venugopal and Jaiswal, 1996; Friling et al., 1992; Liu and Pickett, 1996; Vasliou et al., 1995; Wasserman and Fahl, 1997) . Among these transcription factors, c-Jun, Jun-B, Jun-D, c-Fos, Fra1, Nrf1 and Nrf2 bind to the human NQO1 gene hARE (Li and Jaiswal, 1992; Venugopal and Jaiswal, 1996) . Nrf1 and Nrf2 positively and c-Fos and Fra 1 negatively regulate the hARE-mediated expression and induction of NQO1 gene in response to xenobiotics and antioxidants (Venugopal and Jaiswal, 1996) . Nrf1 and Nrf2 are b-zip (leucine zipper) proteins that do not heterodimerize with each other and require another leucine zipper protein for its activity (Chan et al., 1993; Moi et al., 1994; Venugopal and Jaiswal, 1996) . Recently, Nrf27/7 mice lacking the expression of Nrf2 were generated that showed signi®cantly reduced expression and induction of NQO1 gene indicating a physiological (in vivo) role of transcription factor Nrf2 in the regulation of expression of NQO1 gene (Itoh et al., 1997) .
In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins to regulate AREmediated expression and coordinated induction of NAD(P)H:Quinone Oxidoreductase1 (NQO1) and Glutathione S-transferase Ya (GST Ya) subunit genes. We also demonstrate that heterodimerization and binding of Nrf-Jun proteins require unknown cytosolic factor(s). We further demonstrate that Nrf2 with one mutated leucine in its leucine zipper region performs better than Nrf1 containing two mutated leucines. In addition, we show that cellular levels of Jun proteins play an important role in Nrf1 and Nrf2 regulated ARE-mediated expression and induction.
Results
The nucleotide sequences of human NQO1 gene hARE, mutant NQO1 gene hARE, rat GST Ya gene ARE, mutant GST Ya gene ARE and human collagenase gene TRE are shown in Figure 1 . Both NQO1 and GST Ya gene AREs contain two AP1/AP1 like elements followed by`GC' box. The ARE core sequence`GTGAC***GC' is highly conserved between NQO1 and GST Ya genes. The ARE is known to mediate high basal expression of NQO1 and GST Ya genes and their induction in response to xenobiotics (b-NF) and antioxidants (t-BHQ) (Rushmore et al., 1991; Xie et al., 1995) . Mutations in the ARE core sequences are known to abolish basal expression and induction in response to xenobiotics and antioxidants (Rushmore et al., 1991; Xie et al., 1995) .
Overexpression of transcription factor Nrf1 and cJun individually in transfected Hep-G2 cells led to less than twofold increase in hARE-mediated CAT gene expression ( (Kataoka et al., 1995) . This mutation is known to severely weaken the heterodimerization of v-Jun with other leucine zipper factors (Kataoka et al., 1995) . The replacement of c-Jun with v-Jun showed similar results as with c-Jun. v-Jun combined with Nrf1 and Nrf2 led to signi®cant increases in the hARE-mediated CAT gene expression in transfected Hep-G2 cells. However, replacement of c-Jun or v-Jun with v-JunL3P resulted in signi®cant decreases in Nrf+Jun -mediated hARE regulated CAT gene expression (Figure 2 ; lower left panel). The collagenase gene TRE showed similar results as mutant ARE (Figure 2 lower right panel). However, both mutant ARE-and collagenase gene TRE-mediated expression was increased due to overexpression of c-Jun, presumably through c-Jun+c-Fos pathway. c-Jun is known to form stable heterodimer with c-Fos that binds to the TRE (AP1) and increase the expression of target genes (Angel and Karin, 1991) . Mutant hARE did contain the 5' AP1 like element in 3'?5' orientation making it look like a TRE element. The results with TRE-tk-CAT indicated that Nrf+Jun proteins that mediate hARE-regulated gene expression, are signi®cantly less eective in mediating TREregulated CAT gene expression in transfected cells. These results were expected because TRE-regulated gene expression is known to be mediated by Fos+Jun and not by Nrf+Jun proteins (Angel and Karin, 1991) .
In similar experiments as described above, overexpression of Jun-B and Jun-D along with Nrf1 and Nrf2 also upregulated hARE-mediated CAT gene expression in transfected Hep-G2 cells (Figure 3) . However, overexpression of c-Fos repressed the Nrf1 and Nrf2-mediated upregulation of hARE-mediated CAT gene expression in transfected Hep-G2 cells (Figure 4 ; compare lanes`Nrf1' with`Nrf1+c-Fos' and`Nrf2' with`Nrf2+c-Fos'). In related experiments, overexpression of c-Fos alone also repressed the hARE-mediated basal expression of CAT gene (Figure 4 ; compare c-Fos with LNCX). The repressive eect of c-Fos was highly reproducible. Replacement of hARE-tk-CAT with phNQO1g1.55CAT (1.55 kb of human NQO1 gene promoter driving CAT gene) showed identical results as described above for hARE-tk-CAT plasmid (data not shown).
The treatment of Hep-G2 cells overexpressing Nrf1+c-Jun and Nrf2+c-Jun with dierent concentrations of b-NF showed signi®cant increases in hAREmediated CAT gene expression ( Figure 5 ). The higher doses of b-NF (25 and 50 mM) was more or less similar or less eective in induction of hARE-mediated CAT gene expression as compared to 10 mM b-NF. This presumably may be due to the saturation of system because of overexpression of Nrf+c-Jun. Similar results were also obtained by treatment of transfected Hep-G2 cells with tertbutyl hydroquinone (t-BHQ) (data not shown).
The increasing amount of Nrf1 and Nrf2 with a constant amount of c-Jun resulted in concentration dependent increased expression of hARE-mediated CAT gene ( immunoprecipitated with c-Jun antibody was con®rmed by SDS PAGE, Western blotting and probing with antibodies against Nrf1 and Nrf2 ( Figure 9b ). We also detected small amounts of 110 kDa protein in both Nrf1 and Nrf2 cases that cross-reacted with antibodies against Nrf1 and Nrf2. 110 kDa and 66 kDa Nrf1 proteins are the product of the same gene (Chan et al., 1993) . The peptide sequences of 110 kDa Nrf1 protein is same as 66 kDa Nrf1 protein except that 110 kDa protein is longer at its N-terminus region due to use of a distal 5' ATG (methionine). Similar observations have also been reported for Nrf2 (Moi et al., 1994) . It may be noteworthy that Nrf2 and Nrf1 bands were signi®cantly higher intensity as compared to c-Jun band. This could be due to higher turnover/better labeling of Nrf1 and Nrf2 as compared to c-Jun. In a related experiment, c-Jun co-precipitated with Nrf2 antibody (data not shown). Overexposure of immunoblot in one of the experiment of Figure 9a revealed presence of several proteins in addition to Nrf1 and Nrf2 that associate with c-Jun (Figure 9c ). The c-Jun antibodies also immunoprecipitated Nrf1 and Nrf2 from untransfected Hep-G2 cells (data not shown) indicating the presence of Nrf+Jun complexes in normal (untransfected) cells.
In vitro translated c-Fos and c-Jun proteins bind to the hARE in band shift assays presumably due to presence of AP1/AP1 like elements within the hARE (Figure 10a ). Under similar conditions, Nrf2+c-jun and Nrf1+c-Jun failed to bind to the hARE ( Figure  10a ± data shown only for Nrf2). Preincubation of Nrf2+c-Jun with varying amounts of Hepa-1 nuclear extract did not result in binding of Nrf2+c-Jun to the hARE ( Figure 10b ). However, preincubation of Nrf2+c-Jun with dierent concentrations of cytosolic extract resulted in cytosolic extract concentration dependent binding of Nrf2+c-Jun to the hARE ( Figure 10b ). In the same experiment cytosolic extract by itself did not show any binding to the hARE (Figure 10b ). The mobility of the hARE-Nrf2+c-Jun complex in polyacrylamide gel was similar to that observed with hARE-Hepa-1 nuclear protein complex ( Figure 10b ). In related experiments c-Jun was replaced with v-Jun and v-JunL3P (Figure 10c ). v-JunL3P is a derivative of v-Jun containing third leucine mutated to proline in its leucine zipper region (Kataoka et al., 1995) . This mutation is known to signi®cantly reduce the capacity of v-Jun to form heterodimer with other leucine zipper proteins (Kataoka et al., 1995) . Band shift experiments with hARE and in vitro translated Nrf2+v-Jun showed similar results as Nrf2+c-Jun. Nrf2+v-Jun required preincubation with cytosolic extract to bind to the hARE (Figure 10c complex. It may be noteworthy that lowest band observed in band and super shift assays in Figures 10 and 11 is due to non-speci®c adsorption of protein(s) from rabbit reticulocyte lysate. Therefore, lowest nonspeci®c band was always observed in all cases that used in vitro translated Nrf+Jun proteins for band shift assays. This non-speci®c band has also been observed by other investigators in band shift assays (Nakabeppu et al., 1988) .
A model is presented in Figure 12 to demonstrate the role of Nrf, Jun and Fos proteins in the regulation of ARE-mediated expression and induction of detoxifying enzyme genes.
Discussion
The detoxifying enzymes play an important role in determining the risk of cancer in human and laboratory animals . In other words, development of neoplasia may be regulated by a balance between phase I enzymes (cytochromes P450 and P450 reductase, hydroxylases, lipoxygenases, peroxidases, and oxidases), which activate carcinogens, and phase II enzymes (quinone oxidoreductases, glutathione S-transferases, UDP-glucuronosyl transferases, sufotransferases, epoxide hydrolases etc), which detoxify them . ARE sequences have been characterized in the promoter regions of several genes including NQO1, GST Ya, heme oxygenase (HO) and g-glutamylcysteine synthetase (g-GCS) (Rushmore and Pickett, 1993; Jaiswal, 1994; Nebert, 1994; Prestera et al., 1995; Mulkahy et al., 1997) . ARE-mediated expression and coordinated induction of detoxifying enzymes shift the balance in favor of phase II enzymes and provide the required protection to the cells against electrophilic and oxidative stress due to exposure to chemicals, drugs and xenobiotics. Therefore, the nuclear proteins that bind to the ARE and activate detoxifying enzyme genes are part of a signal cascade that plays an important role in chemoprevention. Nrf1, Nrf2, c-Jun, Jun-B, Jun-D, c-Fos, Fra1 and Fra2 proteins are known to bind to the NQO1 gene hARE Jaiswal, 1992, 1994; Xie et al., 1995; Venugopal and Jaiswal, 1996) . Earlier, we have shown that overexpression of transcription factors Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the hARE-mediated expression of NQO1 gene (Venugopal and Jaiswal, 1996) . Nrf1 and Nrf2 proteins were also found to regulate hARE-mediated induction of NQO1 gene expression in response to b-NF and t-BHQ (Venugopal and Jaiswal, 1996) . In addition, we reported that overexpression of c-Jun led to only marginal increases in the hARE-mediated CAT gene expression (Venugopal and Jaiswal, 1996) .
Nrf1 and Nrf2 are members of leucine zipper (b-zip) proteins (Chan et al., 1993; Moi et al., 1994) . They do not heterodimerize with each other (Chan et al., 1993; Moi et al., 1994; Venugopal and Jaiswal, 1996) . Therefore, it was expected that Nrf1 and Nrf2 heterodimerize with another b-zip protein to bind to the ARE and activate gene expression. In the present study, we have shown that Nrf1 and Nrf2 associate/ Interestingly, binding of in vitro translated Nrf2+c-Jun and Nrf1+c-Jun to the NQO1 gene hARE and GST Ya gene ARE required preincubation of these proteins with Hepa-1 cytosolic extracts. This indicated that Hepa-1 cytosolic extract contains unknown factor(s) that presumably modify Nrf and/or c-Jun for heterodimerization/binding to the ARE. It is possible that the cytosolic factor(s) may be kinase(s)/ phosphatase(s) or redox protein(s) that are required for modi®cation of Nrf/c-Jun leading to their binding to the ARE. It is noteworthy that Nrf and c-Jun both contain phosphorylation sites and cysteines (potential sites for redox regulation). While a vast amount of knowledge is available on phosphorylation/redox regulation of c-Jun protein, the similar information for Nrf proteins are lacking.
We also found that c-Jun concentration within the cells was important for Nrf1 and Nrf2 regulated expression of the CAT gene. The smaller increases in the concentration of c-Jun resulted in the upregulation of hARE-mediated CAT gene expression. However, higher increases in the c-Jun concentration inhibited/ repressed the amount of upregulation of Nrf1 and Nrf2 regulated hARE-mediated CAT gene expression. In addition, overexpression of c-Fos also repressed the hARE-mediated CAT gene expression. These results indicated that higher concentrations of c-Jun and overexpression of c-Fos may lead to the formation of sucient amounts of c-Jun+c-Fos complex which interferes with the binding of positive regulatory factors Nrf1+c-Jun and Nrf2+c-Jun complexes at the ARE binding site. This may also explain why we did not observe a signi®cant eect of overexpression of c-Jun on hARE-mediated CAT gene expression in transfected Hep-G2 cells reported by us previously (Venugopal and Jaiswal, 1996) . We think that in those experiments, we used a concentration of LNCX-c-Jun plasmid which balanced the positive regulation by Nrf1+c-Jun with negative regulation by c-Jun+c-Fos. These observations are consistent with the role of c-Jun in positive and negative regulation of urokinase gene expression (Cesare et al., 1995) . The positive and negative regulation of urokinase gene expression depends on association of c-Jun with other b-zip proteins. c-Jun heterodimerization with ATF-2 results The various experiments also indicated that Nrf2 was more ecient than Nrf1 in upregulation of hAREmediated CAT gene expression. This dierence in the capacities of Nrf1 and Nrf2 may be attributed to the number of mutated leucines in their leucine zipper regions. The leucine zipper region of b-zip proteins are important for homo-or heterodimerization of b-zip proteins for stabilization of the complex and ecient binding at respective cis-element (Angel and Karin, 1991). Nrf1 contains two mutated leucines as compared to one mutated leucine in Nrf2. Therefore, Nrf1-c-Jun complex will be expected to be less stable than Nrf2-cJun complex leading to more ecient performance of Nrf2 as compared to Nrf1.
Other Jun proteins (Jun-B and Jun-D) were found to be more or less equally ecient as c-Jun in association with Nrf1 and Nrf2 leading to the upregulation of hARE-mediated CAT gene expression. Because of similar reasons as observed with c-Jun, Nrf2 combinations with Jun-B and Jun-D were more eective than Nrf1 with Jun-B and Jun-D respectively. Nrf1 and Nrf2 in association with Jun proteins also regulated ARE mediated GST gene expression. This was expected because NQO1 and GST Ya genes are known to be coordinately upregulated by ARE (Rushmore and Pickett, 1993; Jaiswal, 1994) . Recently, a 74.3 kDa protein designated as YABP has been shown to bind to GST Ya gene ARE (Liu and Pickett, 1996) . At present, it is not clear if YABP is related to 65 kDa Nrf1 and 68 kDa Nrf2 proteins or a new class of protein(s). More recently, hMAF, a small human transcription factor is shown to homodimerize and heterodimerize with Nrf1 and Nrf2 (Marini et al., 1997) . Although hMAF-hMAF homodimers and hMAF/Nrf1 and hMAF/Nrf2 heterodimers bind to the similar NF-E2 binding site, they exert functionally opposite eects. The hMAF heterodimerization with Nrf1 and Nrf2 result in activation of b-globin gene expression. However, hMAF homodimerization leads to repression of b-globin gene expression. Because hMAF heterodimerizes with Nrf1 and Nrf2, the role of hMAF, if any, in the regulation of Nrf1+c-Jun and Nrf2+c-Jun regulated hARE-mediated expression of detoxifying enzyme genes remains to be determined. Recently, Nrf2-MafK heterodimer was shown to bind to GST Ya subunit gene ARE leading to the suggestion that it plays a role in the ARE-mediated induction of GST Ya gene expression (Itoh et al., 1997) . The role of mafK in Nrf1/Jun and Nrf2/Jun regulation of ARE-mediated expression of NQO1 gene remains to be determined.
The various steps in the mechanism of signal transduction from xenobiotics and antioxidants to the Nrf1, Nrf2, Jun and Fos proteins that bind to the ARE and regulate ARE-mediated basal expression and coordinated induction of the various detoxifying enzyme genes remain unknown. Xenobiotics and antioxidants undergo metabolism to generate electrophiles and reactive oxygen species (ROS) (Halliwell, 1989; DeLong et al., 1987; Figure 12) . ROS has been implicated in the induction of a number of transcription factors in bacteria, yeast and mammalian cells (Pahl and Baeuerle, 1994) . These include OxyR and SoxRS, which activate more than a dozen genes in bacteria (Zitomer and Lowry, 1992) , yAP-1 and yAP-2 in the yeast, which regulate the expression of oxidative stress response genes superoxide dismutase, glutathione reductase and glucose 6-phosphate dehydrogenase (Zitomer and Lowry, 1992; Kataoka et al., 1995) and Mac-1, which activates catalase gene expression (Jungmann et al., 1993) and NF-kB and AP1 in higher eukaryotic cells which regulate the expression of several genes in immune response and antagonistic signals (Schrech and Baeuerle, 1994) . Two other eukaryotic transcription factors, serum response factor (SRF) and hypoxia response factor HIF-1 have also been suggested to be altered by reactive oxygen (Meyer et al., 1993) . Therefore, it is possible that ROS generated during metabolic activation of xenobiotics and antioxidants may lead to the increased expression and/or modi®cation of Nrf and Jun proteins resulting in increased binding of these proteins to the ARE and/ or increased transcriptional activity of these proteins that bind to the ARE resulting in coordinated induction of the various detoxifying enzyme genes. Recently, it has been reported that the quinonemediated generation of hydroxyl radicals induces the ARE mediated expression of the mouse glutathione Stransferase gene (Pinkus et al., 1996; Favreau and Pickett, 1993) . This correlation remains unknown in the case of AREs from other genes including NQO1 gene hARE. However, hydrogen peroxide (H 2 O 2 ) has been shown to induce the ARE mediated expression of rat GST Ya, rat NQO1 and human NQO1 genes (Li and Jaiswal, 1994; Cesare et al., 1995; Rushmore et al., 1991) and may be an important intermediate in the induction of these genes by the antioxidants and xenobiotics. The role of electrophiles, if any, in the ARE mediated expression and induction of detoxifying enzyme genes remains unknown. The present studies also indicate that signal transduction mechanism for Nrf+c-Jun regulated ARE-mediated expression of detoxifying enzyme genes involves unknown cytosolic factor(s). However, the nature of cytosolic factor(s) remains unknown. The identi®cation of unknown cytosolic factor(s) in the stimulation of Nrf+Jun binding to the hARE is an important step to our understanding of the mechanism of signal transduction from endogenous substances, xenobiotics and antioxidants to the Nrf+Jun proteins (Figure 12 ). The unknown cytosolic factor(s) may be a kinase/phosphatase or redox protein(s) that catalyzes the necessary modi®cation of Nrf and/or Jun proteins to stimulate their heterodimerization and/or binding to the ARE leading to activation of detoxifying enzyme genes expression. The previous studies demonstrating increased binding of nuclear factors to the hARE and increased expression of hARE-mediated CAT gene expression in resonse to dithiothretol anf b-mercaptoethanol (Li and Jaiswal, 1994) , may suggest that unknown cytosolic factor(s) may be redox protein(s).
However, the identi®cation of unknown cytosolic factor(s) as kinase(s)/phosphatase(s) could not be ruled out.
In conclusion, we have shown that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Jun, Jun-B and Jun-D) proteins and upregulate ARE-mediated basal expression of detoxifying enzyme genes and coordinated induction in response to xenobiotics and antioxidants. Nrf-c-Jun association/ binding to the ARE requires unknown cytosolic factor(s). Nrf2 containing one mutation in its leucine zipper region was more ecient in upregulation of hARE-mediated NQO1 and GST Ya ARE -mediated GST genes expression, as compared to Nrf1 that contains two mutated leucines in its leucine zipper region. We have also shown that c-Fos+c-Jun comlex when present in suciently high amounts, interferes with the binding of positive regulatory complex Nrf+Jun at the ARE binding site resulting in repression of hARE-mediated CAT gene expression. . In vitro translated Nrf2+c-Jun were preincubated with dierent concentrations of Hepa-1 nuclear (NE) or cytosolic (CE) extracts at 378C for 15 min for modi®cations/heterodimerization and used in band shift assays with hARE. hARE was also incubated with Hepa-1 nuclear (NE) and cytosolic extracts (CE). (c) hARE was incubated with 0.5 mg in vitro translated Nrf2+v-Jun or Nrf2+v-JunL3P previously preincubated with 20 mg of Hepa-1 cytosolic extract at 378C for 15 min for modi®cation and heterodimerization. In addition, hARE was also incubated with 2 mg of Hepa-1 nuclear extract (NE) or with 0.5 mg of Nrf2+c-Jun preincubated with 20 mg cytosolic extract. (d) Band shift assay with GST Ya gene ARE. Hepa-1 cytosolic extract (15 0006g, 1 h supernatant)
Materials and methods

Plasmid construction
Nucleotide sequences of human NQO1 gene ARE (hARE), mutant hARE, rat GST Ya gene ARE, mutant GST Ya gene ARE and human collagenase gene TRE are shown in Figure 1 . The construction of hARE-, mutant hARE-and TRE-thymidine kinase (tk)-CAT plasmids have been described (Xie et al., 1995) . Both strands of the GST Ya gene ARE (region between 7722 to 7689 of rat GST Ya gene (Rushmore et al., 1991) with BamHI ends were synthesized, annealed, kinased, and cloned at the BamHI site of the plasmid pBLCAT2 to generate recombinant plasmid pGST Ya ARE-tk-CAT. Purine to pyrimidine (and vice versa) changes were incorporated to construct mutant GST Ya gene ARE-tk-CAT plasmid. Both mutant NQO1 gene hARE and mutant GST Ya gene ARE contained mutations in the ARE core sequences resulting in the loss of ARE-mediated gene expression and induction (Rushmore et al., 1991; Xie et al., 1995) . The construction of expression plasmids LNCX-c-Jun, LNCX-Jun-B, LNCXJun-D, LNCX-c-Fos, LNCX-Fra1, LNCX-Nrf1 and LNCX-Nrf2 have been previously described (Venugopal and Jaiswal, 1996) .
Cell culture and cotransfection of reporter and expression plasmids
Human hepatoblastoma (Hep-G2) cells were grown in monolayer cultures as described (Li and Jaiswal, 1992) . Five micrograms of reporter plasmid hARE-tk-CAT, mutant hARE-tk-CAT, GST Ya ARE-tk-CAT, mutant GST Ya ARE-tk-CAT or TRE-tk-CAT was mixed with 10 micrograms of expression plasmid LNCX vector alone or LNCX-c-Jun, LNCX-Jun-B, LNCX-Jun-D, LNCX-v-Jun; LNCX-v-JunL3P; LNCX-c-Fos, LNCX-Fra1, LNCX-Nrf1 and LNCX-Nrf2 and cotransfected in Hep-G2 cells by procedures as described (Venugopal and Jaiswal, 1996) . Five micrograms of Rous sarcoma virus (RSV)-b-galactosidase (b-gal) plasmid was included in each transfection to normalize transfection eciency. The transfected Hep-G2 cells were harvested 48 h after transfection, homogenized by sonication and analysed for the levels of b-gal and CAT activity. In several experiments, the transfected cells were treated with several dierent concentrations of b-naphthoavone (b-NF) and tert-butylhydroquinone (t-BHQ). In related experiments, the concentration of an expression plasmid was changed with a constant concentration of a second expression plasmid.
The proteins encoded by expression plasmids in the transfected Hep-G2 cells were characterized and measured by Western analysis and probing with speci®c antibodies as described previously (Venugopal and Jaiswal, 1996) . The densitometric analysis of Western blots indicated increase of two-to threefold in the expression of transcription factor(s) in transfected cells as compared with the vector-transfected controls. The speci®c fold inductions upon transfection with 5 mg of expression plasmids were as follows: LNCX-Nrf1R, 1.0-fold; LNCX-Nrf1C, 2.1-fold; LNCX-Nrf2R, 1.0-fold; LNCX-Nrf2C, 2.8-fold; LNCX-c-Jun, 3.1-fold; LNCX-Jun-D, 2.4-fold; LNCX-Jun-B, 2.2-fold; LNCX-v-Jun, 3.6-fold; LNCX-v-JunL3P, 3.3-fold. Increase in the amount of expression plasmids from 5 ± 10 mg of DNA led to further increases in the fold expression of respective transcription factors. The fold increases with 10 mg expression plasmids were two times higher than observed with 5 mg expression plasmids. Therefore, the amount of transcription factor(s) produced from their respective cDNA(s) correlated with the amount of expression plasmid(s) used in transfections (data not shown). LNCX-Nrf1R and LNCX-Nrf2R contained the respective cDNA in reverse orientation and failed to overexpress the proteins in transfected Hep-G2 cells.
Antibodies and immunoprecipitation
Anti-c-Jun (against peptide MLTQQLQTF) of murine cJun, Anti-c-Fos (against peptide YGKVEQLSPEEEEKR-RIRRERNKMAAA of mouse c-Fos were obtained from Dr Kevin Ryder (NIH, Bethesda). These peptides are speci®c for c-Jun and c-Fos and are selected from regions distinct from DNA binding domain or transcriptional activation domain. Antibodies raised against these peptides speci®cally detect the presence of corresponding proteins and do not interfere in DNA binding or activation of transcription. These antibodies have been used to detect c-Jun and c-Fos in super shift assays (Nakabeppu et al., 1988; Li and Jaiswal, 1992) . Nrf1 and Nrf2 antibodies were purchased from Santa Cruz Biotechnology, Inc.). These are speci®cally designed to detect Nrf1 and Nrf2 proteins in super shift assays. The Nrf1 and Nrf2 antibodies have been previously used to detect Nrf1 and Nrf2 in super shift assays (Venugopal and Jaiswal, 1996) .
Hep-G2 cells were grown as monolayers in 100 mm petri dishes and co-transfected with LNCX-Nrf2C, LNCX-Nrf1C with LNCX-c-Jun to overexpress the respective proteins. The cells from ®ve transfected petri dishes were washed with PBS, scraped and nuclei isolated by procedure as described (Dignam et al., 1983; Kadonaga, 1991) . The nuclei were lysed in 1 ml of RIPA buer (50 mM Tris pH 7.4, 150 mM NaCl, 0.5% Triton X-100, 11.6 mM deoxycholic acid and 0.1% SDS). One half of the nuclear extract was mixed with 40 ml of preimmune serum and another half with similar amount of c-Jun antiserum and incubated with shaking at 48C for 1 h. The immunoprecipitate was adsorbed on 25 ml of protein A sepharose in eppendorf tubes for 2 h at 48C. The protein A sepharose beads were collected by centrifugation and washed with wash buer I (100 mM Tris, pH 8.7, 500 mM lithium chloride and 140 mM of b-mercaptoethanol) followed by wash buer II (100 mM Tris, pH 8.7, 2 M KCl and 140 mM b-mercaptoethanol) and wash buer III (1% SDS in RIPA buer). The beads were suspended in 20 ml of sample buer (50 mM Tris pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol blue and 10% glycerol) and loaded on a 12% polyacrylamide gel. The proteins were electrophoresed and the gel was incubated in methanol : acetic acid : water (4 : 5 : 1) to ®x the proteins. The gel was also treated with amplify (NAMP 100) from Amersham to amplify the 35 S signal. The gel was dried and autoradiographed. Similar experiment was also performed with untransfected Hep-G2 cells.
In vitro transcription and translation
The coding sequences of Nrf2, Nrf1, c-Jun, v-Jun and vJunL3P were separately subcloned in pBluescriptSK + vector. v-JunL3P is a mutant form of v-Jun (Kataoka et al., 1995) . The third leucine in the leucine zipper region of v-Jun was mutated to proline to generate v-JunL3P. This mutation is known to signi®cantly reduce the ability of vJun to heterodimerize with other leucine zipper proteins resulting in the loss of DNA binding (Kataoka et al., 1995) . Plasmid DNAs carrying various cDNAs (Nrf2, Nrf1 and c-Jun) were digested with appropriate restriction enzymes and treated with proteinaseK following phenol/ chloroform extraction and ethanol precipitation. To synthesize 5' capped RNA, linearized DNA templates were transcribed in vitro using a commercial mRNA capping kit from Promega. RNA was puri®ed according to the manufacturer's manual. One microgram of RNA was translated in vitro using a rabbit reticulocyte lysate (50 ml of total reaction volume) with or without 50 mCi of [ 35 S]methionine (*100 Ci/mmol)] as directed by the supplier (Promega Biotech). In vitro translated Nrf2, Nrf1, c-Jun, v-Jun and v-JunL3P were stored at 7808C. 35 S-methionine-labeled translation products were analysed on 12.5% SDS-polyacrylamide gel by procedures as described (Laemmli, 1970) . A 14 C-labeled protein mixture was used for molecular weight standards. After electrophoresis, the gel was ®xed with 10% acetic acid/30% methanol, treated with NAMP 100 from Amersham to amplify the 35 S signal. The gel was dried and autoradiographed. In addition, the in vitro translated products were con®rmed by SDS ± PAGE and Western analysis.
DNA binding
The nuclear extract from Hepa-1 cells was prepared according to the procedure of Kadonaga (1991) . In vitro translated Nrf2, Nrf1, c-Jun, v-Jun and v-JunL3P were mixed in various combinations in equimolar ratios and incubated at 378C for 15 min in absence and presence of Hepa-1 nuclear or cytosolic (15 000 g, 1 h supernatant) extracts. DNA binding of in vitro translated proteins to the NQO1 gene hARE and GST Ya gene ARE were performed by band shift assays by procedures as described below. 40 000 ± 50 000 c.p.m. (52 ng) of the 32 P-labeled hARE was mixed with 4 mg poly (dI-dC).poly (dI.dC) and 0.2 ± 0.5 mg of in vitro translated and preincubated (378C for 15 min for heterodimerization) of Nrf2, Nrf1, c-Jun, v-Jun and v-JunL3P individually and in various combinations in the presence of 25 mM HEPES (K + ), pH 7.8, 12.5 mM MgCl 2 , 1 mM DTT, 20% glycerol (v/v), 0.1% Nonidet P-40 and 0.1 M KCl and incubated at room temperature for 20 min. The samples were electrophoresed at 25 mA, gel-dried under vacuum, and autoradiographed. In related experiments, the concentration of DTT was varied from 0 ± 10 mM in band shift assays to determine its eect on binding of Nrf-Jun proteins to the hARE. In other experiments, NQO1 gene hARE was replaced with GST Ya gene ARE. In related experiments, the in vitro translated c-Jun+Nrf2 proteins were pre-incubated with speci®c Nrf2 and c-Jun antibodies before band shift assays with hARE.
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The abbreviations used are: ARE, antioxidant response element; hARE, human NQO1 gene ARE; GST Ya ARE, GST Ya subunit gene ARE; TRE; TPA response element; NQO1, AND(P)H:Quinone Oxidoreductase1; GST Ya, Glutathione S-transferase Ya gene; Nrf1 and Nrf2, NF-E2 related nuclear transcription factor 1 and 2; c-Jun, Jun-B, Jun-D, c-Fos and Fra1, Leucine zipper containing b-zip family of nuclear transcription factors; b-NF, b-naphthoavone; t-BHQ, tert-butyl hydroquinone; bp, base pairs.
